Allergy Therapeutics PLC
05 March 2007
TR-1: notification of major interests in shares
1. Identity of the issuer or the underlying issuer of existing Allergy Therapeutics plc
shares to which voting rights are attached:
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the acquisition of
shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification Fidelity International Limited (FIL)
obligation:
4. Full name of shareholder(s) (if different from 3.): See 8 below
5. Date of the transaction and date on which the threshold is 27 February 2007
crossed or reached:
6. Date on which issuer notified: 1 March 2007
7. Notified details:
A: Voting rights attached to shares
Class/type of shares Situation previous Resulting situation after the triggering transaction
to the Triggering
if possible using the transaction
ISIN CODE Number of Number of Number of Number of voting rights % of voting rights
Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
GB00B02LCQ05 11,597,973 - - 11,093,473 - 13.54%
ORD £0.001
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting
instrument Period/ Date that may be acquired if rights
the instrument is
exercised/ converted
Total (A+B)
Number of voting rights % of voting rights
11,093,473 13.54%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively
held, if applicable:
Fidelity International Limited (FIL) is the parent holding company for various direct and indirect subsidiaries,
including Fidelity Fund Management Limited (FFML), Fidelity Investment Services Ltd (FISL), Fideilty Gestion (FIGEST),
Fideilty Investments Advisory (Korea) Limited (FIAKL), Fidelity Investments Management (Hong Kong) Limited (FIMHK),
Fidelity Pension Management (FPM), Fidelity Investments Japan (FIJ) and Fidelity Investments International (FII),
investment managers for various non-US investment companies and institutional clients.
UK Nominee Management Company Shares Held
State Str Bk and Tr Co LNDN FPM 131,284
Northern Trust London FPM 602,000
Midland Securities Services FPM 174,300
Mellon Bank FPM 684,400
JP Morgan, Bournemouth FPM 947,136
JP Morgan, Bournemouth FISL 5,724,798
JP Morgan, Bournemouth FIL 1,501,512
Brown Bros Harrimn Ltd Lux FIL 869,043
Bank of New York, Brussels FPM 459,000
Total 11,093,473
Proxy Voting:
9. Name of the proxy holder: Fidelity International Limited (FIL)
10. Number of voting rights proxy holder will cease to hold: 504,500
11. Date on which proxy holder will cease to hold voting rights: 27 February 2007
12. Additional information: The disclosure threshold was crossed due to a non-market
transaction
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.